The current stock price for Lexicon Pharmaceuticals Inc (LXRX) is $1.23. The stock experienced a significant increase during the last trading session, reaching $6.0 after opening at $1.21. It dipped to a low of $0.7 before ultimately closing at $1.05.
Lexicon Pharmaceuticals Inc’s stock has had a calm market performance.
52-week price history of LXRX Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Lexicon Pharmaceuticals Inc’s current trading price is -43.68% away from its 52-week high, while its distance from the 52-week low is 331.95%. The stock’s price range during this period has fluctuated between $0.28 and $2.17. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 4.04 million for the day, which was evidently lower than the average daily volume of 4.12 million over the last three months.
Financial Performance and Market Capitalization
Lexicon Pharmaceuticals Inc (LXRX) has experienced a quarterly rise of 86.77% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 444.90M and boasts a workforce of 103 employees.
Analysts’ Ratings For Lexicon Pharmaceuticals Inc
As of right now, 1 analyst is rating Lexicon Pharmaceuticals Inc as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.7328, with a change in price of +0.8166. Similarly, Lexicon Pharmaceuticals Inc recorded 10,054,546 in trading volume during the last 100 days, posting a change of +228.74%.
LXRX Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for LXRX stands at 0.86. Similarly, the long-term debt-to-equity ratio is also 0.51.
LXRX Stock Stochastic Average
Lexicon Pharmaceuticals Inc’s raw stochastic average for the past 50 days is currently at 68.54%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 40.37%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 37.65% and 38.78%, respectively.
LXRX Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The metric has seen a significant loss of -39.36% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 61.16%. Over the past 30 days, the price of LXRX has fallen by 33.65%. And in the last five days, it has surged by 20.10%.
